https://doi.org/10.1038/srep30689
K
Keisuke Otani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
134
Papers
1.3K
Citations
18
h-index
30
i10-index
Keisuke Otani is an academic researcher from Harvard University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Renal cell carcinoma treatment & Prostate Cancer Treatment and Research. The author has an h-index of 18, co-authored 114 publications.
ORCID: 0000-0002-8275-0651Papers by this author
worksCell-cycle-controlled radiation therapy was effective for treating a murine malignant melanoma cell line in vitro and in vivo
2016 · Scientific Reports · 50 citations
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
2025 · Nature Communications · 25 citations
https://doi.org/10.1038/s41467-024-55140-x
Prostate Cancer Somatic Mutations and Outcomes of Salvage Radiation and Hormonal Therapy for Post-Prostatectomy Recurrence
2024 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2024.07.875
Bystander Effects in Osteoblasts and Osteoclasts: Comparison Between X- and Proton-Irradiation
2025 · International Journal of Particle Therapy · 0 citations
https://doi.org/10.1016/j.ijpt.2025.101203
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy
2025 · npj Precision Oncology · 0 citations
https://doi.org/10.1038/s41698-025-01201-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat